Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup

Main|Search|PHGKB


Last Posted: Jun 23, 2017

---

• Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup 
  C Ko et al, Genetics in Medicine, June 22, 2017
• Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy.  
  Burns Charlotte et al. European journal of human genetics : EJHG 2017 Jun 25(7) 809-815
• Hypertrophic Cardiomyopathy in Childhood: Risk Management Through Family Screening.  
  Munk Kim et al. The Journal of pediatrics 2017 May
• Attitudes, knowledge and consequences of uncertain genetic findings in hypertrophic cardiomyopathy  
  C Burns et al, Eur J Human Genetics, May 3, 2017
• Follow-up care by a genetic counsellor for relatives at risk for cardiomyopathies is cost-saving and well-appreciated: a randomised comparison.  
  Nieuwhof Karin et al. European journal of human genetics : EJHG 2017 Feb 25(2) 169-175
• Effect of Moderate-Intensity Exercise Training on Peak Oxygen Consumption in Patients With Hypertrophic Cardiomyopathy: A Randomized Clinical Trial.  
  Saberi Sara et al. JAMA 2017 Mar

more